WO2004074438A3 - Antagonistes de ccr8 - Google Patents

Antagonistes de ccr8 Download PDF

Info

Publication number
WO2004074438A3
WO2004074438A3 PCT/US2004/004394 US2004004394W WO2004074438A3 WO 2004074438 A3 WO2004074438 A3 WO 2004074438A3 US 2004004394 W US2004004394 W US 2004004394W WO 2004074438 A3 WO2004074438 A3 WO 2004074438A3
Authority
WO
WIPO (PCT)
Prior art keywords
ccr8
benzenesulfonamide
ccr8 antagonists
antagonists
bicyclicaryl
Prior art date
Application number
PCT/US2004/004394
Other languages
English (en)
Other versions
WO2004074438A2 (fr
Inventor
Jian Jin
Jeffrey K Kerns
Dongchuan Shi
Feng Wang
Yonghui Wang
Original Assignee
Smithkline Beecham Corp
Jian Jin
Jeffrey K Kerns
Dongchuan Shi
Feng Wang
Yonghui Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Jian Jin, Jeffrey K Kerns, Dongchuan Shi, Feng Wang, Yonghui Wang filed Critical Smithkline Beecham Corp
Publication of WO2004074438A2 publication Critical patent/WO2004074438A2/fr
Publication of WO2004074438A3 publication Critical patent/WO2004074438A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne certains aryl-benzènesulfonamides bicycliques substitués et leur utilisation pour l'inhibition du récepteur de chimiokine dénommé CCR8. La structure générique des composés décrits est celle d'un benzène sulfonamide de formule (I). (I)
PCT/US2004/004394 2003-02-14 2004-02-13 Antagonistes de ccr8 WO2004074438A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44745003P 2003-02-14 2003-02-14
US60/447,450 2003-02-14

Publications (2)

Publication Number Publication Date
WO2004074438A2 WO2004074438A2 (fr) 2004-09-02
WO2004074438A3 true WO2004074438A3 (fr) 2005-02-24

Family

ID=32908441

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/004394 WO2004074438A2 (fr) 2003-02-14 2004-02-13 Antagonistes de ccr8

Country Status (1)

Country Link
WO (1) WO2004074438A2 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687931C (fr) 2007-05-31 2016-05-24 Boehringer Ingelheim International Gmbh Antagonistes des recepteurs ccr2 et utilisations de ceux-ci
EP2379525B1 (fr) 2008-12-19 2015-07-29 Boehringer Ingelheim International GmbH Pyrimidine-4 carboxamides cycliques en tant qu'antagonistes du récepteur ccr2 pour le traitement d'inflammations, de l'asthme et des broncho-pneumopathies chroniques obstructives
WO2010105243A1 (fr) 2009-03-13 2010-09-16 Agios Pharmaceuticals, Inc. Procédés et compositions pour des troubles liés à la prolifération cellulaire
CA2758071C (fr) 2009-04-06 2018-01-09 Agios Pharmaceuticals, Inc. Modulateurs de pyruvate kinase m2, compositions therapeutiques et methodes d'utilisation associees
JP5764555B2 (ja) 2009-06-29 2015-08-19 アジオス ファーマシューティカルズ， インコーポレイテッド 治療組成物および関連する使用方法
IN2012DN00471A (fr) 2009-06-29 2015-06-05 Agios Pharmaceuticals Inc
EP2525790B1 (fr) 2009-10-21 2020-05-27 Agios Pharmaceuticals, Inc. Procédés et compositions pour troubles associés à la prolifération cellulaire
EP2491145B1 (fr) 2009-10-21 2016-03-09 Agios Pharmaceuticals, Inc. Procédés et compositions pour des troubles relatifs à la prolifération cellulaire
WO2011072174A1 (fr) * 2009-12-09 2011-06-16 Agios Pharmaceuticals, Inc. Composés thérapeutiquement actifs destinés au traitement d'un cancer caractérisé par une mutation idh
ES2524829T3 (es) 2009-12-17 2014-12-12 Boehringer Ingelheim International Gmbh Nuevos antagonistas del receptor CCR2 y usos de los mismos
JP5658272B2 (ja) * 2009-12-17 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ２の新規アンタゴニスト及びこれらの使用
JP2013526507A (ja) 2010-05-12 2013-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
WO2011141477A1 (fr) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh Nouveaux antagonistes du récepteur ccr2, leur procédé de production et leur utilisation en tant que médicaments
EP2571870B1 (fr) 2010-05-17 2015-01-21 Boehringer Ingelheim International GmbH Antagonistes de ccr2 et leurs utilisations
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
US8962656B2 (en) 2010-06-01 2015-02-24 Boehringer Ingelheim International Gmbh CCR2 antagonists
JP5837091B2 (ja) 2010-12-17 2015-12-24 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼｍ２（ｐｋｍ２）調節剤としての新規ｎ−（４−（アゼチジン−１−カルボニル）フェニル）−（ヘテロ−）アリールスルホンアミド誘導体
ES2569712T3 (es) 2010-12-21 2016-05-12 Agios Pharmaceuticals, Inc. Activadores de PKM2 bicíclicos
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
RU2675656C2 (ru) 2011-05-03 2018-12-21 Аджиос Фармасьютикалз, Инк. Способы применения активаторов пируваткиназы
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
EP2731941B1 (fr) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Antagonistes ccr2, nouveaux et sélectifs
CN115536635A (zh) 2012-01-06 2022-12-30 法国施维雅药厂 治疗活性化合物及其使用方法
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
NZ706999A (en) 2012-10-15 2018-12-21 Agios Pharmaceuticals Inc Inhibitors of mutant isocitrate dehydrogenase and therapeutical uses thereof
WO2015003355A2 (fr) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Composés thérapeutiquement actifs et leurs méthodes d'utilisation
WO2015003360A2 (fr) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Composés thérapeutiquement actifs et leurs méthodes d'utilisation
EP3019480B1 (fr) 2013-07-11 2020-05-06 Agios Pharmaceuticals, Inc. Composés 2,4- ou 4,6-diaminopyrimidine comme inhibiteurs d'idh2 mutantes pour le traitement du cancer
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
NZ723859A (en) 2014-03-14 2023-01-27 Servier Lab Pharmaceutical compositions of therapeutically active compounds and their uses
DK3307271T3 (da) 2015-06-11 2023-10-09 Agios Pharmaceuticals Inc Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer
AU2016287584B2 (en) 2015-07-02 2020-03-26 Centrexion Therapeutics Corporation (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4yl)methanone citrate
PT3362066T (pt) 2015-10-15 2021-11-16 Celgene Corp Terapia de combinação para tratar malignidades
WO2017066566A1 (fr) 2015-10-15 2017-04-20 Agios Pharmaceuticals, Inc Polythérapie pour le traitement de malignités
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
JP2023540661A (ja) * 2020-07-03 2023-09-26 ナンキン イムノファージ バイオテック カンパニー リミテッド ＣＣＲ８阻害剤を使用してＴｒｅｇｓを標的とする方法および組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009787A1 (fr) * 1989-02-27 1990-09-07 The Du Pont Merck Pharmaceutical Company Nouveaux sulfamides servant de radiosensibilisateurs
US6133442A (en) * 1994-12-20 2000-10-17 Hoffmann-La Roche Inc. Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009787A1 (fr) * 1989-02-27 1990-09-07 The Du Pont Merck Pharmaceutical Company Nouveaux sulfamides servant de radiosensibilisateurs
US6133442A (en) * 1994-12-20 2000-10-17 Hoffmann-La Roche Inc. Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists

Also Published As

Publication number Publication date
WO2004074438A2 (fr) 2004-09-02

Similar Documents

Publication Publication Date Title
WO2004074438A3 (fr) Antagonistes de ccr8
WO2004073619A3 (fr) Antagonistes du recepteur ccr8
WO2003028641A3 (fr) Antagonistes du recepteur de la mch
WO2005113534A3 (fr) Antagonistes de chimiokines cxcr1 et cxcr2
WO2006044504A8 (fr) Antagonistes aux récepteurs de cgrp
WO2006020959A3 (fr) Heterocycles benzo-condenses substitues
WO2002081430A3 (fr) Nouveaux benzylideneamino guanidines et leurs utilisations comme ligands de recepteurs de la melanocortine
WO2006047196A3 (fr) Antagonistes de recepteurs cgrp
WO2002060900A8 (fr) Antagonistes vis-a-vis de la fonction mcp-1 et procedes d'utilisation
WO2006004741A3 (fr) 3-aminocyclopentanecarboxamides utilises en tant que modulateurs des recepteurs des chimiokines
WO2006068826A3 (fr) Inhibiteurs de la kinase erbb a base de 2-pyrimidinyle pyrazolopyridine
WO2005000820A3 (fr) Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1
WO2004082822A3 (fr) Procedes permettant d'isoler la forme i cristalline de la 5-azacytidine
EP2078721A3 (fr) Composés thiéno-pyrimidines ayant une activité fongicide
WO2004092166A3 (fr) Antagonistes des recepteurs cgrp
WO2006004684A8 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de la chimiokine
WO2006099268A3 (fr) Antagonistes du recepteur du cgrp
WO2004091514A3 (fr) Antagonistes des recepteurs de cgrp
WO2006047415A3 (fr) Composes inhibiteurs du facteurs xa
WO2003024928A3 (fr) Nouveau derives d'aminoazetidine, d'aminopyrrolidine et d'aminopiperidine
GEP20104880B (en) Carboxamide derivatives as muscarinic receptor antagonists
WO2007019191A3 (fr) Inhibiteurs de la thiazolopyrimidine kinase
WO2006044449A3 (fr) Antagonistes des recepteurs du cgrp (peptide lie au gene de la calcitonine)
WO2007014008A3 (fr) Inhibiteur benzenesulfonamide de recepteur de chimiokine ccr2
WO2005060959A8 (fr) Derives de pyrazone et leur utilisation en tant qu'antagonistes du recepteur de l'orexine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase